The Role of Angiopoietins in Cardiovascular Outcomes of Kidney Transplant Recipients- An Ancillary Study From the FAVORIT.
Natalie GendyLiam BrownMary Kate StauntonKanika GargNora Hernandez GarcilazoLong QianYu YamamotoUgochukwu UgwuowoWassim ObeidLama Al-QusairiAndrew BostomSherry G MansourPublished in: American journal of nephrology (2024)
Angpt-2 may be a useful prognostic tool for future CVD in KTRs. Combining angiopoietins with clinical markers may tailor follow-up to mitigate CVD risk.
Keyphrases